| CAS NO: | 2131803-93-3 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| Cas No. | 2131803-93-3 |
| 别名 | 2-((4,4-二甲基-1-氧化硫代苯并二氢吡喃-6-基)乙炔基)嘧啶-5-羧酸 |
| Canonical SMILES | O=C(C1=CN=C(C#CC2=CC=C3C(C(C)(C)CCS3=O)=C2)N=C1)O |
| 分子式 | C18H16N2O3S |
| 分子量 | 340.4 |
| 储存条件 | Store at -20℃ |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1]. WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1]. [1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1. |
m.cnreagent.com